Healthcare & Life Sciences

MiDiagnostics

Canada
series-c-plus
series-c-plus
Stage
2
Investors

About

MiDiagnostics develops rapid point-of-care diagnostic systems and consumables using silicon photonics and microfluidics technology to perform molecular and immunoassays near the patient.

Explore MiDiagnostics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.